Vericel Corp logo

Vericel Corp

NAS:VCEL (USA)  
$ 57.31 +0.27 (+0.47%) 11:08 PM EST
814.86
P/B:
10.91
Volume:
102.14K
Avg Vol (2M):
418.41K
Trade In:
Volume:
102.14K
Avg Vol (2M):
418.41K

Business Description

Description
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company, specialized in various therapies for sports medicine and severe burn care markets. It markets two cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane) and Epicel (cultured epidermal autografts). The company operates in one reportable segment: the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of specific diseases.
Name Current Vs Industry Vs History
Cash-To-Debt 1.04
Equity-to-Asset 0.66
Debt-to-Equity 0.38
Debt-to-EBITDA 9.34
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 12.31
Distress
Grey
Safe
Beneish M-Score -2.7
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 59.93
9-Day RSI 56.32
14-Day RSI 57.76
6-1 Month Momentum % 27.97
12-1 Month Momentum % 70.1

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.61
Quick Ratio 4.23
Cash Ratio 2.46
Days Inventory 78.84
Days Sales Outstanding 78.68
Days Payable 116.08

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -1.5
Shareholder Yield % -1.64

Financials (Next Earnings Date:2025-02-28 Est.)

VCEL's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:VCEL

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Vericel Corp Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 226.844
EPS (TTM) ($) 0.07
Beta 1.16
Volatility % 46.87
14-Day RSI 57.76
14-Day ATR ($) 2.409762
20-Day SMA ($) 57.2095
12-1 Month Momentum % 70.1
52-Week Range ($) 32.31 - 61.49
Shares Outstanding (Mil) 49.36

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Vericel Corp Filings

Filing Date Document Date Form
No Filing Data

Vericel Corp Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Vericel Corp Frequently Asked Questions

What is Vericel Corp(VCEL)'s stock price today?
The current price of VCEL is $57.31. The 52 week high of VCEL is $61.49 and 52 week low is $32.31.
When is next earnings date of Vericel Corp(VCEL)?
The next earnings date of Vericel Corp(VCEL) is 2025-02-28 Est..
Does Vericel Corp(VCEL) pay dividends? If so, how much?
Vericel Corp(VCEL) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1